Biofil Chemicals

50.23
+0.75
(1.52%)
Market Cap
81.74 Cr
EPS
0.44
PE Ratio
133.78
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
91.87
52 Week low
46.50
PB Ratio
4.38
Debt to Equity
0.03
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
34.55 %
Net Income Growth
16.67 %
Cash Flow Change
2,272.73 %
ROE
20.37 %
ROCE
3.38 %
EBITDA Margin (Avg.)
-23.33 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
6
14
14
13
23
30
37
23
30
41
41
Expenses
5
12
11
11
22
28
34
21
29
39
40
EBITDA
1
1
3
1
1
2
2
2
1
1
1
Operating Profit %
13 %
7 %
19 %
8 %
4 %
6 %
4 %
6 %
4 %
2 %
3 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
1
1
2
1
1
2
2
1
1
1
1
Tax
0
0
1
0
0
0
1
0
0
0
0
Net Profit
1
1
2
1
1
1
1
1
1
1
1
EPS in ₹
0.36
0.48
1.10
0.29
0.30
0.74
0.77
0.44
0.34
0.44
0.40

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
14
24
22
24
24
42
33
19
31
47
Fixed Assets
9
9
9
9
10
10
10
9
9
9
Current Assets
5
15
13
15
14
32
24
9
22
38
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
5
15
13
15
14
32
24
9
22
39
Total Liabilities
14
24
22
24
24
42
33
19
31
47
Current Liabilities
5
13
9
11
11
28
17
2
14
29
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Equity
8
11
13
13
14
15
16
17
17
18
Reserve & Surplus
-8
-5
-4
-3
-3
-1
-0
1
1
2
Share Capital
16
16
16
16
16
16
16
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
0
0
-0
0
0
-0
-0
2
Investing Activities
-0
-0
-1
-0
-1
-0
-0
-0
0
0
Operating Activities
0
0
1
1
1
1
1
-0
-0
2
Financing Activities
0
0
-0
0
-0
-1
-1
0
0
-0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
46.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.03 %
0.00 %
0.00 %
0.00 %
DIIs
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
0.08 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
35.72 %
37.15 %
37.62 %
37.95 %
37.97 %
37.84 %
37.87 %
38.04 %
38.13 %
38.09 %
37.97 %
37.67 %
38.03 %
37.27 %
38.02 %
38.18 %
Others
17.38 %
15.95 %
15.48 %
15.15 %
15.13 %
15.27 %
15.23 %
15.06 %
14.97 %
15.01 %
15.13 %
15.43 %
15.04 %
15.83 %
15.08 %
14.92 %
No of Share Holders
0
29,874
29,164
28,720
27,834
29,961
29,280
28,257
27,475
26,741
26,123
25,864
26,581
25,480
26,422
26,114

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators